| 0.25 0.001 (0.44%) | 11-29 10:46 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.36 | 1-year : | 0.43 |
| Resists | First : | 0.3 | Second : | 0.37 |
| Pivot price | 0.25  |
|||
| Supports | First : | 0.2 | Second : | 0.17 |
| MAs | MA(5) : | 0.24 |
MA(20) : | 0.26 |
| MA(100) : | 0.68 |
MA(250) : | 1.89 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 37.2 |
D(3) : | 31.1 |
| RSI | RSI(14): 45.2 |
|||
| 52-week | High : | 4.19 | Low : | 0.2 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ YTEN ] has closed below upper band by 44.9%. Bollinger Bands are 77.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 62 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.25 - 0.25 | 0.25 - 0.25 |
| Low: | 0.22 - 0.22 | 0.22 - 0.22 |
| Close: | 0.25 - 0.25 | 0.25 - 0.25 |
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.
Tue, 28 Nov 2023
Why SpringWorks Shares Are Trading Higher By Around 14%; Here ... - Investing.com UK
Mon, 27 Nov 2023
Yield10 Bioscience (YTEN) Price Target Increased by 23.53% to 3.57 - Nasdaq
Thu, 16 Nov 2023
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript - Yahoo Finance
Tue, 31 Oct 2023
Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land - Yahoo Finance
Wed, 18 Oct 2023
Yield10 Bioscience Exercises Option to Finalize an Exclusive ... - BioSpace
Wed, 11 Oct 2023
Yield10 Bioscience Provides Update on Recent Advancements in ... - BioSpace
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Agricultural Inputs
|
|
| Shares Out | 0 (M) |
| Shares Float | 12 (M) |
| Held by Insiders | 1.093e+007 (%) |
| Held by Institutions | 18.1 (%) |
| Shares Short | 131 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.409e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -9 % |
| Return on Assets (ttm) | 778.2 % |
| Return on Equity (ttm) | -103.8 % |
| Qtrly Rev. Growth | 147000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -205.83 |
| EBITDA (p.s.) | -3.94595e+006 |
| Qtrly Earnings Growth | -2.4 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.01 |
| Price to Cash Flow | 16.03 |
| Dividend | 0 |
| Forward Dividend | 130040 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|